You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Details for New Drug Application (NDA): 076923

✉ Email this page to a colleague

« Back to Dashboard

NDA 076923 describes LIOTHYRONINE SODIUM, which is a drug marketed by Xgen Pharms, Biocon Pharma, Dr Reddys Labs Sa, Pharmobedient, Sigmapharm Labs Llc, Sun Pharm, Teva Pharms Usa, Watson Labs, and Zydus Lifesciences, and is included in ten NDAs. It is available from seventeen suppliers. Additional details are available on the LIOTHYRONINE SODIUM profile page.

The generic ingredient in LIOTHYRONINE SODIUM is liothyronine sodium. There are four drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the liothyronine sodium profile page.

Summary for 076923

Tradename:	LIOTHYRONINE SODIUM
Applicant:	Xgen Pharms
Ingredient:	liothyronine sodium
Patents:	0

Pharmacology for NDA: 076923

Suppliers and Packaging for NDA: 076923

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
LIOTHYRONINE SODIUM	liothyronine sodium	INJECTABLE;INJECTION	076923	ANDA	XGen Pharmaceuticals DJB, Inc.	39822-0151	39822-0151-1	1 VIAL in 1 CARTON (39822-0151-1) / 1 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	EQ 0.01MG BASE/ML
Approval Date:	Aug 17, 2005	TE:		RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.